USA • New York Stock Exchange • NYSE:BLND • US09352U1088
Taking everything into account, BLND scores 3 out of 10 in our fundamental rating. BLND was compared to 278 industry peers in the Software industry. The financial health of BLND is average, but there are quite some concerns on its profitability. BLND is quite expensive at the moment. It does show a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.79% | ||
| ROE | -17.03% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.99% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.38 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.54 | ||
| Quick Ratio | 2.54 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 238 | ||
| Fwd PE | 30.04 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 3 / 10 to BLND.
ChartMill assigns a valuation rating of 2 / 10 to BLEND LABS INC-A (BLND). This can be considered as Overvalued.
BLEND LABS INC-A (BLND) has a profitability rating of 1 / 10.
The financial health rating of BLEND LABS INC-A (BLND) is 6 / 10.